YLL020C Antibody

What is YLL020C and why is it significant for yeast research?

YLL020C is classified as a "dubious open reading frame" in Saccharomyces cerevisiae (Baker's yeast, strain ATCC 204508/S288c) with a phenotype rating of "++" in oleic acid sensitivity assays. Though designated as dubious, it demonstrates functional significance in yeast metabolism, particularly in relation to its adjacent gene KNS1 . YLL020C's classification as dubious stems from computational predictions suggesting it may not encode an actual protein, yet experimental evidence indicates phenotypic effects when this region is disrupted. Research into such ORFs helps elucidate genome organization, gene regulation, and previously uncharacterized functional elements in yeast .

What are the fundamental characteristics of the YLL020C antibody?

The YLL020C antibody is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) YLL020C protein. This IgG isotype antibody is antigen-affinity purified and designed specifically for research applications involving S. cerevisiae . The antibody recognizes the protein encoded by UniProt accession Q07811 and is validated for use in Western blotting (WB) and ELISA applications . It is supplied in liquid form with a storage buffer consisting of 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative .

What experimental applications has the YLL020C antibody been validated for?

The YLL020C antibody has been validated primarily for ELISA and Western blot (WB) applications for the identification of YLL020C protein in Saccharomyces cerevisiae samples . In Western blotting applications, the antibody can detect native and denatured forms of the protein in yeast protein preparations, following standard protocols such as those described for yeast protein extraction by Kornitzer (2002) . For immunofluorescence microscopy, while not explicitly validated, similar yeast antibodies have been successfully employed using FITC filters to detect fluorescent-tagged conjugates, suggesting potential utility in this application with appropriate optimization .

How can YLL020C antibody be used to investigate the phenotypic effects of oleic acid sensitivity in yeast?

To investigate oleic acid sensitivity phenotypes associated with YLL020C, researchers can employ the antibody in a comparative analysis workflow. Begin by cultivating wild-type and YLL020C-deficient yeast strains in media with and without oleic acid supplementation. Extract proteins using the Kornitzer method and perform Western blotting with the YLL020C antibody to quantify expression levels under different conditions .

The experimental design should include:

• Growth curve analysis of wild-type and YLL020C-deficient strains in varying oleic acid concentrations

• Protein extraction from cultures at different growth phases

• Western blot analysis using the YLL020C antibody with actin as a loading control

• Quantification of relative protein expression using densitometry

• Correlation of protein levels with observed phenotypic data

This approach allows researchers to establish whether the "++" oleic acid sensitivity phenotype correlates with altered YLL020C protein expression or modification patterns .

What methodologies are recommended for studying the functional relationship between YLL020C and its adjacent hit gene KNS1?

To investigate the functional relationship between YLL020C and KNS1, implement a multi-faceted approach combining genetic and proteomic techniques:

• Genetic interaction studies: Create single and double knockouts of YLL020C and KNS1, then compare phenotypes under various stress conditions, particularly oleic acid exposure.

• Co-immunoprecipitation: Use the YLL020C antibody for immunoprecipitation followed by mass spectrometry to identify potential protein-protein interactions between YLL020C and KNS1 products.

• Expression correlation analysis: Perform Western blots with both YLL020C and KNS1 antibodies across different growth conditions to determine if their expression patterns correlate.

• Chromatin immunoprecipitation: Investigate potential regulatory relationships by determining if one gene's product affects the transcription of the other.

• Subcellular localization studies: Use fluorescence microscopy with the YLL020C antibody (conjugated to a fluorophore) to examine whether YLL020C and KNS1 proteins co-localize within the cell .

This comprehensive approach will help elucidate whether these adjacent genes participate in related pathways or processes despite YLL020C's classification as a dubious ORF.

How can multiplex serology approaches be adapted for studying antibody responses to YLL020C in different experimental conditions?

To adapt multiplex serology approaches for studying YLL020C antibody responses, researchers can implement a fluorescent-bead based multiplex assay similar to those developed for SARS-CoV-2 serology . This methodology allows simultaneous detection of multiple antibody responses and can be customized for yeast proteins as follows:

• Recombinantly express YLL020C protein and relevant yeast proteins of interest.

• Couple each protein to distinctly colored fluorescent beads.

• Incubate the protein-coupled beads with serum samples from experimental subjects.

• Detect bound antibodies using fluorescently-labeled secondary antibodies.

• Analyze using flow cytometry to quantify antibody responses to each protein.

This approach enables researchers to assess potential cross-reactivity between YLL020C and other yeast proteins, as well as to study the antibody response dynamics under different experimental conditions . The multiplexed format significantly increases efficiency compared to traditional single-antigen assays, allowing comprehensive profiling of antibody responses in a time- and sample-efficient manner.

What is the recommended protocol for using YLL020C antibody in Western blot applications?

When using the YLL020C antibody for Western blot applications, follow this optimized protocol for yeast samples:

• Protein extraction:

  • Harvest yeast cells from mid-log phase cultures

  • Extract proteins using the Kornitzer method (2002)

  • Quantify protein concentration using Bradford or BCA assay

• SDS-PAGE separation:

  • Load 20-30 μg of protein per lane

  • Separate proteins on a 10-12% SDS-PAGE gel at 120V

• Transfer:

  • Transfer proteins to PVDF membrane at 100V for 1 hour or 30V overnight

  • Verify transfer efficiency using Ponceau S staining

• Immunoblotting:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with YLL020C antibody at 1:1000 dilution in blocking buffer overnight at 4°C

  • Wash 3x with TBST, 5 minutes each

  • Incubate with HRP-conjugated anti-rabbit secondary antibody at 1:5000 for 1 hour

  • Wash 3x with TBST, 5 minutes each

• Detection:

  • Develop using enhanced chemiluminescence substrate

  • Image using a digital imaging system or expose to X-ray film

  • For loading control, re-probe with anti-actin antibody (1:2000)

For optimal results, include both positive control (wild-type yeast extract) and negative control (YLL020C deletion strain extract) samples in each experiment.

How should researchers optimize ELISA protocols for YLL020C antibody detection?

To optimize ELISA protocols for YLL020C antibody detection, follow this methodological approach:

• Plate preparation:

  • Coat high-binding 96-well plates with purified recombinant YLL020C protein (1-5 μg/ml in carbonate buffer, pH 9.6)

  • Incubate overnight at 4°C

  • Wash 3x with PBS-T (PBS + 0.05% Tween-20)

• Blocking:

  • Block with 2% BSA in PBS for 1-2 hours at room temperature

  • Wash 3x with PBS-T

• Sample incubation:

  • Add diluted samples (serum or extracted antibodies) in blocking buffer

  • Perform serial dilutions (1:100 to 1:12800) to determine optimal concentration

  • Incubate for 2 hours at room temperature or overnight at 4°C

  • Wash 4x with PBS-T

• Antibody detection:

  • Add HRP-conjugated anti-rabbit IgG (1:5000 in blocking buffer)

  • Incubate for 1 hour at room temperature

  • Wash 4x with PBS-T

• Development:

  • Add TMB substrate and incubate for 15-30 minutes in the dark

  • Stop reaction with 2N H₂SO₄

  • Read absorbance at 450 nm with 570 nm reference

• Optimization parameters:

  • Antigen concentration: Test 0.5-10 μg/ml

  • Antibody dilution: Test 1:500-1:5000

  • Incubation time: Test 1-4 hours at room temperature vs. overnight at 4°C

  • Blocking buffer: Compare BSA vs. non-fat milk at 1-5%

Include positive and negative controls in each assay, and generate a standard curve for quantitative applications.

What strategies can be employed to improve specificity when using YLL020C antibody in experimental applications?

To improve specificity when using YLL020C antibody in experimental applications, implement the following strategies:

• Pre-absorption with related proteins:

  • Incubate the antibody with lysates from YLL020C deletion strains

  • This removes antibodies that may cross-react with other yeast proteins

• Competitive blocking:

  • Pre-incubate the antibody with purified recombinant YLL020C protein

  • Compare results with and without competition to confirm specificity

• Validation in knockout models:

  • Test the antibody in YLL020C knockout strains as negative controls

  • Absence of signal confirms specificity for the target protein

• Cross-reactivity testing:

  • Test the antibody against a panel of related yeast proteins

  • Document any cross-reactivity patterns to account for in data interpretation

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, non-fat milk, normal serum)

  • Optimize concentration (1-5%) and incubation times

• Stringent washing:

  • Increase washing stringency by adding higher concentrations of detergent (0.05-0.1% Tween-20)

  • Implement additional washing steps to remove non-specific binding

• Antibody titration:

  • Determine the minimum effective concentration that maintains specific signal

  • Working at this concentration minimizes background and cross-reactivity

Implementing these strategies will significantly improve signal-to-noise ratio and ensure experimental results accurately reflect YLL020C-specific interactions.

How can researchers address non-specific binding issues when using YLL020C antibody in Western blots?

When encountering non-specific binding issues with YLL020C antibody in Western blots, implement this systematic troubleshooting approach:

• Optimize blocking conditions:

  • Test alternative blocking agents: 5% non-fat milk, 3-5% BSA, or commercial blocking buffers

  • Extend blocking time to 2 hours at room temperature or overnight at 4°C

• Adjust antibody concentration:

  • Titrate primary antibody from 1:500 to 1:5000 dilution

  • Reduce secondary antibody concentration to 1:10000

• Modify washing protocol:

  • Increase number of washes to 5-6 times

  • Extend washing time to 10 minutes per wash

  • Add 0.1-0.5M NaCl to washing buffer to disrupt low-affinity interactions

• Pre-absorb the antibody:

  • Incubate diluted antibody with membrane containing proteins from YLL020C knockout yeast

  • Collect and use the pre-absorbed antibody solution for your experiment

• Sample preparation improvements:

  • Add protease inhibitor cocktail during extraction

  • Ensure complete protein denaturation by heating samples at 95°C for 5 minutes

  • Use fresh β-mercaptoethanol in sample buffer

• Gel running conditions:

  • Optimize polyacrylamide percentage based on target protein size

  • Run gel at lower voltage (80-100V) to improve separation

• Data interpretation strategies:

  • Always include YLL020C knockout control to identify non-specific bands

  • Compare banding patterns across different experimental conditions

  • Use molecular weight markers to identify expected target size

  • Consider using specialized low-background detection reagents for cleaner results

What controls should be included when validating experimental results using YLL020C antibody?

A comprehensive control strategy for validating experimental results with YLL020C antibody should include:

• Genetic controls:

  • Positive control: Wild-type S. cerevisiae (strain ATCC 204508/S288c)

  • Negative control: YLL020C deletion/knockout strain

  • Overexpression control: Strain with YLL020C under a strong promoter

• Antibody controls:

  • Primary antibody omission: Samples processed without YLL020C antibody

  • Secondary antibody only: To detect non-specific secondary antibody binding

  • Isotype control: Non-specific rabbit IgG at the same concentration

  • Pre-immune serum: If available, from the same rabbit pre-immunization

• Technical controls:

  • Loading control: Anti-actin antibody to normalize protein loading

  • Molecular weight marker: To confirm target band size

  • Cross-reactivity control: Testing antibody against related proteins

  • Peptide competition: Pre-incubation with immunizing peptide/protein

• Procedural validation:

  • Replicate samples: Technical and biological replicates

  • Antibody titration: Testing multiple antibody dilutions

  • Alternative detection method: Confirming results with a second technique

  • Positive reference sample: Known positive sample across experiments for consistency

• Control table for experimental design:

Implementing this comprehensive control strategy ensures reliable and reproducible results while providing appropriate context for data interpretation .

How should researchers interpret conflicting data when studying YLL020C function using antibody-based methods?

When confronted with conflicting data in YLL020C research using antibody-based methods, apply this structured analytical framework:

• Evaluate antibody performance:

  • Confirm antibody specificity using YLL020C deletion strains

  • Test for lot-to-lot variability if using different antibody batches

  • Verify storage conditions and potential degradation of antibody

• Assess methodological differences:

  • Compare extraction protocols across experiments

  • Evaluate differences in detection systems and sensitivity

  • Consider variations in experimental conditions (temperature, pH, buffer composition)

• Analyze biological variables:

  • Growth phase differences between samples

  • Media composition and nutrient availability

  • Genetic background variations in yeast strains

  • Stress conditions that might affect YLL020C expression

• Implement resolution strategies:

  • Repeat experiments with standardized protocols

  • Use multiple detection methods (Western blot, ELISA, immunofluorescence)

  • Employ orthogonal techniques (qPCR, mass spectrometry) to validate findings

  • Quantify results with appropriate statistical analysis

• Contextual interpretation framework:

  • Consider YLL020C's classification as a dubious ORF

  • Evaluate potential functional overlap with adjacent gene KNS1

  • Assess phenotypic data alongside molecular data

  • Examine oleic acid sensitivity context, as YLL020C shows a "++" phenotype in this condition

When presenting conflicting data, transparently report all experimental conditions and control measures. This approach not only maintains scientific integrity but may also reveal important biological insights about the contextual function of YLL020C.

What methodological approaches can resolve data inconsistencies when comparing YLL020C expression across different experimental conditions?

To resolve data inconsistencies when comparing YLL020C expression across different experimental conditions, implement this comprehensive methodological framework:

• Standardize sample preparation:

  • Harvest cells at identical growth phases across experiments

  • Implement a unified protein extraction protocol

  • Quantify protein concentration using the same method consistently

  • Prepare and store samples under identical conditions

• Normalize data appropriately:

  • Use multiple loading controls (actin, tubulin, total protein stain)

  • Implement internal calibration samples across experimental batches

  • Apply appropriate normalization algorithms for densitometry

  • Account for background signal in quantification

• Expand detection methods:

  • Complement Western blot with ELISA quantification

  • Validate protein levels with mass spectrometry

  • Correlate protein data with transcript levels via RT-qPCR

  • Consider absolute quantification approaches

• Implement statistical rigor:

  • Increase biological replicates (minimum n=3)

  • Perform appropriate statistical tests (ANOVA for multiple conditions)

  • Calculate confidence intervals for expression measurements

  • Use statistical methods designed for handling batch effects

• Systematic validation approach:

  • Create a reference panel of samples representing different conditions

  • Process these reference samples alongside experimental samples

  • Develop a standard curve for quantification

  • Document all experimental parameters meticulously

• Data integration strategy:

  • Plot all data points rather than just means

  • Visualize data using multiple representation methods

  • Analyze trends rather than absolute values when appropriate

  • Consider multivariate analysis to identify confounding variables

This systematic approach not only resolves inconsistencies but transforms them into valuable insights about condition-dependent YLL020C expression patterns.

How does YLL020C's classification as a dubious ORF impact experimental design and data interpretation?

YLL020C's classification as a dubious ORF necessitates specific considerations in experimental design and data interpretation:

• Experimental design adaptations:

  • Include genomic context analysis beyond the YLL020C sequence

  • Design primers and probes that distinguish between YLL020C and adjacent genes

  • Implement controls that account for potential overlapping transcripts

  • Create deletion constructs that minimize disruption to adjacent genomic regions

  • Consider the potential for unannotated functional elements within the YLL020C region

• Protein expression verification:

  • Use multiple antibody epitopes to confirm protein expression

  • Employ mass spectrometry to validate the existence of the protein product

  • Tag YLL020C genomically and verify expression through the tag

  • Distinguish between potential spurious transcription and functional expression

• Functional assessment framework:

  • Evaluate phenotypes in both single (YLL020C) and double (YLL020C + adjacent genes) knockouts

  • Test function under diverse stress conditions, particularly oleic acid exposure

  • Assess potential regulatory roles beyond protein-coding function

  • Consider the possibility of small peptides or regulatory RNAs from this region

• Interpretation guidelines:

  • Interpret oleic acid sensitivity phenotype (++) in light of potential genomic interactions

  • Consider alternative hypotheses explaining the observed phenotypes

  • Maintain skepticism about direct protein function while remaining open to non-canonical roles

  • Contextualize findings within the growing literature on dubious ORFs in yeast

This nuanced approach acknowledges the complexity of genomic organization while enabling rigorous scientific investigation of YLL020C's potential functional significance despite its dubious classification.

What emerging technologies might enhance the specificity and applications of YLL020C antibody research?

Emerging technologies poised to enhance YLL020C antibody research include:

• Advanced antibody engineering:

  • Single-domain antibodies (nanobodies) for improved specificity

  • Recombinant antibody fragments with enhanced epitope access

  • CRISPR-engineered hybridomas for improved monoclonal production

  • Site-specific antibody conjugation for precise labeling

• High-resolution imaging techniques:

  • Super-resolution microscopy to visualize subcellular localization

  • Expansion microscopy for enhanced spatial resolution

  • Correlative light and electron microscopy for structural context

  • Live-cell imaging with photoactivatable antibody conjugates

• Single-cell analysis platforms:

  • Mass cytometry (CyTOF) for multiplexed protein detection

  • Single-cell Western blotting for cell-to-cell variation analysis

  • Microfluidic antibody-based sorting systems

  • Spatial transcriptomics combined with antibody staining

• Multiplexed detection systems:

  • Fluorescence-activated cell sorting (FACS) with multi-parameter analysis

  • Sequential antibody labeling and stripping for multiplexed detection

  • Barcoded antibody systems for simultaneous protein quantification

  • Flow cytometry adaptation for yeast cells with modified cell wall preparation

• Computational and AI approaches:

  • Machine learning algorithms for improved image analysis

  • Computational prediction of cross-reactivity

  • Systems biology integration of antibody-based datasets

  • AI-assisted epitope mapping and antibody design

These technologies will enable researchers to address fundamental questions about YLL020C's expression, localization, and function with unprecedented precision and contextual understanding, potentially resolving the ambiguity surrounding its dubious ORF classification.

How can researchers integrate antibody-based detection of YLL020C with functional genomics approaches to better understand its role in yeast metabolism?

To integrate antibody-based detection of YLL020C with functional genomics for a comprehensive understanding of its metabolic role, implement this multi-layered research strategy:

• Integrated screening approach:

  • Perform systematic genetic interaction screens with YLL020C deletion

  • Correlate genetic interactions with proteomic changes detected by YLL020C antibody

  • Map metabolic pathways affected by YLL020C disruption using metabolomics

  • Use antibody-based ChIP-seq to identify potential DNA interactions

• Temporal dynamics analysis:

  • Monitor YLL020C protein levels during metabolic shifts using Western blotting

  • Correlate protein expression changes with transcriptomic data

  • Track subcellular localization changes under different metabolic conditions

  • Measure post-translational modifications in response to metabolic stressors

• Multi-omics data integration:

  • Generate condition-specific protein interaction networks using immunoprecipitation

  • Correlate protein abundance with metabolite profiles

  • Integrate protein localization data with organelle-specific functions

  • Map protein-protein interactions onto known metabolic pathways

• Functional validation pipeline:

  • Use antibody-detected expression patterns to guide CRISPR-based genomic editing

  • Validate antibody-identified interactions with targeted metabolic enzyme assays

  • Correlate antibody-detected protein levels with oleic acid metabolism measurements

  • Engineer synthetic genetic circuits to test hypothetical functions based on antibody data

• Data integration framework:

This integrated approach transforms YLL020C antibody from a mere detection tool into a central component of a systems biology investigation, potentially revealing unexpected functions despite its classification as a dubious ORF .

What are the key limitations researchers should consider when using YLL020C antibody in their studies?

When employing YLL020C antibody in research, scientists should acknowledge these key limitations to ensure appropriate experimental design and data interpretation:

• Antibody-specific limitations:

  • Polyclonal nature may lead to batch-to-batch variability

  • Limited validation across diverse applications beyond Western blot and ELISA

  • Potential cross-reactivity with structurally similar yeast proteins

  • Absence of epitope mapping data to interpret partial protein detection

• Target-related constraints:

  • YLL020C's classification as a dubious ORF introduces uncertainty about protein expression

  • Limited knowledge about post-translational modifications affecting antibody recognition

  • Potential regulatory relationships with adjacent gene KNS1 may complicate interpretation

  • Expression levels may be below detection limits under standard conditions

• Methodological considerations:

  • Optimization requirements for each new application or condition

  • Need for comprehensive controls, particularly YLL020C deletion strains

  • Detection sensitivity limitations in complex samples

  • Challenges in distinguishing specific from non-specific signals

• Interpretative challenges:

  • Difficulty correlating antibody-detected signals with phenotypic observations

  • Incomplete understanding of YLL020C function despite observed oleic acid sensitivity

  • Limited comparative data across different yeast strains and growth conditions

  • Potential functional redundancy complicating knockout studies

How can researchers effectively combine YLL020C antibody studies with other experimental approaches to generate comprehensive insights?

To generate comprehensive insights about YLL020C, researchers should implement a multi-faceted approach that integrates antibody-based detection with complementary experimental techniques:

• Genetic approaches integration:

  • Correlate antibody-detected protein levels with phenotypes of deletion and overexpression strains

  • Use CRISPR-based gene editing to introduce point mutations and assess impact on antibody detection

  • Perform genetic interaction screens and map results against antibody-detected expression patterns

  • Conduct synthetic genetic array analysis to identify functional relationships

• Transcriptomics correlation:

  • Compare protein levels detected by antibody with mRNA expression data

  • Analyze transcript structure to validate or challenge dubious ORF classification

  • Map transcription start sites and termination sites relative to the YLL020C gene

  • Assess alternative splicing or RNA processing that might affect antibody detection

• Metabolomics integration:

  • Correlate YLL020C protein levels with changes in lipid metabolism, particularly in oleic acid conditions

  • Perform metabolic flux analysis in wild-type versus YLL020C mutant strains

  • Identify metabolic signatures associated with YLL020C expression levels

  • Map metabolic changes onto known yeast metabolic networks

• Structural biology approaches:

  • Use antibody-purified protein for structural studies

  • Perform epitope mapping to understand antibody binding regions

  • Correlate structural predictions with antibody accessibility

  • Assess protein-protein interactions through structural modeling

• Comprehensive workflow integration:

This integrated approach transforms YLL020C antibody from a simple detection tool into a central component of a systems biology investigation, enhancing the reliability and significance of findings while addressing the inherent limitations of any single experimental technique .

What future research directions might emerge from comprehensive studies of YLL020C using antibody-based approaches?

Comprehensive antibody-based studies of YLL020C may catalyze several promising research directions:

• Redefining dubious ORF classification criteria:

  • Using YLL020C as a model to establish new functional validation methodologies

  • Developing antibody-based screening approaches for systematic assessment of dubious ORFs

  • Creating integrated bioinformatic and experimental pipelines for ORF reannotation

  • Establishing standards for protein expression validation of computationally ambiguous genes

• Novel regulatory mechanism exploration:

  • Investigating potential non-canonical functions (regulatory RNA, small peptides)

  • Examining position-dependent effects on adjacent genes like KNS1

  • Exploring condition-specific expression patterns, particularly under oleic acid stress

  • Assessing potential involvement in chromosome architecture and DNA organization

• Methodological advancements:

  • Developing improved antibody-based techniques for low-abundance yeast proteins

  • Creating standardized protocols for dubious ORF protein detection

  • Establishing multiplex detection systems for simultaneous monitoring of adjacent genes

  • Advancing single-cell protein detection methods for yeast

• Evolutionary biology insights:

  • Comparative analysis of YLL020C homologs across yeast species

  • Investigating evolutionary conservation despite dubious classification

  • Assessing selective pressures on this genomic region

  • Exploring potential horizontal gene transfer or gene conversion events

• Translational applications:

  • Exploring potential biotechnological applications of YLL020C in oleic acid metabolism

  • Developing YLL020C-based biosensors for oleic acid detection

  • Investigating potential industrial applications in lipid processing

  • Using insights from YLL020C to understand similar genomic regions in pathogenic fungi

These research directions not only advance our understanding of YLL020C but also contribute to broader knowledge about genome organization, protein function validation, and the ongoing refinement of genome annotation standards across species.